Suggestions
Tamara Lovi, MBA
Commercial & Operations Leader; establishing & driving winning teams & strategies to build successful brands and businesses.
Tamara Lovi, MBA is a strategic and innovative commercial and operations leader currently serving as the Chief Business Officer at ROSE LifeScience Inc.16 She is known for her passion for collaboration, challenging the status quo, and driving profitable growth.1
Professional Background
Tamara is recognized for her expertise in:
- Establishing and driving winning teams
- Developing successful brand strategies
- Building and growing market share
- Leveraging consumer insights
Her leadership style focuses on empowering teams and fostering innovation to achieve business objectives.
Career Highlights
At ROSE LifeScience Inc., Tamara plays a crucial role in the company's commercial and operational strategies. Her position as Chief Business Officer indicates her involvement in high-level decision-making and strategic planning for the organization.6
Personal Values
Tamara is an advocate for gender parity in the workplace. She believes that having equal representation at all levels of an organization is essential for ensuring diverse perspectives and driving success.6 This commitment to empowering women is also reflected in her personal life, as evidenced by a letter she wrote to her daughter on the topic of women's empowerment.5
Online Presence
Tamara maintains an active presence on LinkedIn, where she frequently shares insights on leadership, business strategies, and industry events.234 Her LinkedIn profile serves as a platform for professional networking and sharing her expertise in commercial and operations leadership.
Highlights
HEALTH CANADA CANNABIS CONSULTATION It’s no secret that if an industry is going to be successful, it needs to work together. In the still-burgeoning world of regulated cannabis, that happens with open collaboration — with all governments — at all levels.
Indeed, I’m extremely grateful for Health Canada’s recent proposed amendments to the Cannabis Act, positioned to create efficiencies across our industry. Why? Because the more efficiencies we create, the better we can protect public health, safety and responsible business…together. Talking. Listening. Sharing insights. It all matters, greatly. And Health Canada’s recent call to licensed producers for open consultation is what collaboration looks like. I’m so proud to answer that call with full support, on behalf of ROSE. I urge Health Canada to implement these changes quickly, to bring much needed relief to our young industry.
I see other improvement opportunities which also need to be addressed. I am confident Health Canada will tackle these with industry, in the future:
- Licensing around research
- Security clearance for directors
- Security measures (video and records access)
- Pre-Roll weight limit guidelines
**Consultation response deadline: July 8th 2024.
https://lnkd.in/excVJ2cf
Proud to be joining my fellow cannabis industry colleagues at #GrassontheHill in Ottawa to help drive change and ensure our young industry is successful in achieving its initial objectives, when legalized 5 years ago today.
Shauna Levy Megan McCrae Pierre M Killeen George Smitherman Julia Cameron Tabitha Davis, RAC
